No deviation in use of Rights Issue proceeds through June 2026

Compliance View source PDF Explain this filing

VINEETLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.7%Reaction day

₹37.60

prior close

₹37.98

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-2.7pendingpending

Next day

———

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vineet Laboratories reported no deviation or variation in using Rights Issue proceeds for the quarter ended June 30, 2026. It raised Rs 2,996.81 lakh through equity rights issued January 1-30, 2026. Use included Rs 284 lakh for bank-loan repayment, Rs 33.75 lakh for a 50-kilolitre-per-day effluent treatment plant, Rs 293.65 lakh for capacity expansion and Rs 670.66 lakh for general corporate purposes. Crisil Ratings monitored the issue; committee and auditor comments were nil.

Likely market impact

Funds were used within the approved plan with no diversion, supporting investor confidence, but the filing gives no direct earnings impact.